Ni X, Wei Y, Li X, Pan J, Fang B, Zhang T
Nat Rev Urol. 2024; 21(10):593-614.
PMID: 38671281
DOI: 10.1038/s41585-024-00875-x.
Belitskin D, Munne P, Pant S, Anttila J, Suleymanova I, Belitskina K
Mol Oncol. 2023; 18(3):547-561.
PMID: 37872868
PMC: 10920082.
DOI: 10.1002/1878-0261.13545.
Koistinen H, Kovanen R, Hollenberg M, Dufour A, Radisky E, Stenman U
IUBMB Life. 2023; 75(6):493-513.
PMID: 36598826
PMC: 10159896.
DOI: 10.1002/iub.2700.
Sedlack A, Saleh-Anaraki K, Kumar S, Ear P, Lines K, Roper N
Cancers (Basel). 2022; 14(22).
PMID: 36428741
PMC: 9688518.
DOI: 10.3390/cancers14225646.
Adamiecki R, Hryniewicz-Jankowska A, Ortiz M, Li X, Porter-Hansen B, Nsouli I
Cancers (Basel). 2022; 14(21).
PMID: 36358740
PMC: 9654339.
DOI: 10.3390/cancers14215321.
Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients.
Zaragoza-Huesca D, Nieto-Olivares A, Garcia-Molina F, Ricote G, Montenegro S, Sanchez-Canovas M
Cancers (Basel). 2022; 14(13).
PMID: 35804878
PMC: 9264764.
DOI: 10.3390/cancers14133106.
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer.
Lu L, Cole A, Huang D, Wang Q, Guo Z, Yang W
Biomolecules. 2022; 12(2).
PMID: 35204704
PMC: 8961580.
DOI: 10.3390/biom12020203.
Quantitative Detection of Cathepsin B Activity in Neutral pH Buffers Using Gold Microelectrode Arrays: Toward Direct Multiplex Analyses of Extracellular Proteases in Human Serum.
Song Y, Wright J, Anderson M, Rajendran S, Ren Z, Hua D
ACS Sens. 2021; 6(10):3621-3631.
PMID: 34546741
PMC: 9398763.
DOI: 10.1021/acssensors.1c01175.
Hepsin regulates TGFβ signaling via fibronectin proteolysis.
Belitskin D, Pant S, Munne P, Suleymanova I, Belitskina K, Hongisto H
EMBO Rep. 2021; 22(11):e52532.
PMID: 34515392
PMC: 8567232.
DOI: 10.15252/embr.202152532.
Hepsin Promotes Epithelial-Mesenchymal Transition and Cell Invasion Through the miR-222/PPP2R2A/AKT Axis in Prostate Cancer.
Li R, Li J, Yang H, Bai Y, Hu C, Wu H
Onco Targets Ther. 2020; 13:12141-12149.
PMID: 33268993
PMC: 7701367.
DOI: 10.2147/OTT.S268025.
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research.
Saranyutanon S, Deshmukh S, Dasgupta S, Pai S, Singh S, Singh A
Cancers (Basel). 2020; 12(9).
PMID: 32957478
PMC: 7563251.
DOI: 10.3390/cancers12092651.
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones.
Blay V, Li M, Ho S, Stoller M, Hsieh H, Houston D
Acta Pharm Sin B. 2020; 10(7):1309-1320.
PMID: 32874830
PMC: 7452031.
DOI: 10.1016/j.apsb.2019.09.008.
L1CAM, CA9, KLK6, HPN, and ALDH1A1 as Potential Serum Markers in Primary and Metastatic Colorectal Cancer Screening.
Tieng F, Abu N, Sukor S, Mohd Azman Z, Mahamad Nadzir N, Lee L
Diagnostics (Basel). 2020; 10(7).
PMID: 32630086
PMC: 7400057.
DOI: 10.3390/diagnostics10070444.
Bispecific antibodies: a novel approach for targeting prominent biomarkers.
Gupta A, Kumar Y
Hum Vaccin Immunother. 2020; 16(11):2831-2839.
PMID: 32614706
PMC: 7746243.
DOI: 10.1080/21645515.2020.1738167.
Tmprss12 is required for sperm motility and uterotubal junction migration in mice†.
Larasati T, Noda T, Fujihara Y, Shimada K, Tobita T, Yu Z
Biol Reprod. 2020; 103(2):254-263.
PMID: 32529245
PMC: 7401031.
DOI: 10.1093/biolre/ioaa060.
Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers.
Mukai S, Yamasaki K, Fujii M, Nagai T, Terada N, Kataoka H
Int J Mol Sci. 2020; 21(8).
PMID: 32290402
PMC: 7215454.
DOI: 10.3390/ijms21082663.
Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.
Patel G, Chugh N, Tripathi M
Cancers (Basel). 2019; 11(10).
PMID: 31547070
PMC: 6826557.
DOI: 10.3390/cancers11101405.
Cell surface-anchored serine proteases in cancer progression and metastasis.
Martin C, List K
Cancer Metastasis Rev. 2019; 38(3):357-387.
PMID: 31529338
PMC: 6893142.
DOI: 10.1007/s10555-019-09811-7.
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells.
Willbold R, Wirth K, Martini T, Sultmann H, Bolenz C, Wittig R
Cell Death Dis. 2019; 10(8):601.
PMID: 31399560
PMC: 6689070.
DOI: 10.1038/s41419-019-1830-8.
Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.
Pawar N, Buzza M, Antalis T
Cancer Res. 2019; 79(2):301-310.
PMID: 30610085
PMC: 6335149.
DOI: 10.1158/0008-5472.CAN-18-1745.